Old Web
English
Sign In
Acemap
>
authorDetail
>
Aaron Lisberg
Aaron Lisberg
Medicine
Pathology
Cancer research
Tyrosine-kinase inhibitor
Phases of clinical research
5
Papers
75
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MA 02.07 A Phase II Study of Pembrolizumab in EGFR Mutant, PD-L1+, Tyrosine Kinase Inhibitor (TKI) Naïve Patients with Advanced NSCLC
2017
Journal of Thoracic Oncology
Aaron Lisberg
Jamie Hunt
N. Reese
T. Wang
P. Coluzzi
Marshall L. Spiegel
Krikor Bornazyan
J. Carroll
John Madrigal
Blanca A Ledezma
Melody A. Mendenhall
J Bui
H.Lu
A Cummings
Z. Noor
Jonathan W. Goldman
Edward B. Garon
Show All
Source
Cite
Save
Citations (0)
MA 02.07 A Phase II Study of Pembrolizumab in EGFR Mutant, PD-L1+, Tyrosine Kinase Inhibitor (TKI) Naïve Patients with Advanced NSCLC
2017
Journal of Thoracic Oncology
Aaron Lisberg
Jamie Hunt
N. Reese
T. Wang
P. Coluzzi
Marshall L. Spiegel
Krikor Bornazyan
James Carroll
John Madrigal
Blanca A Ledezma
Melody A. Mendenhall
J Bui
H.Lu
Amy Lauren Cummings
Z. Noor
Jonathan W. Goldman
Edward B. Garon
Show All
Source
Cite
Save
Citations (0)
MA 02.07 A Phase II Study of Pembrolizumab in EGFR Mutant, PD-L1+, Tyrosine Kinase Inhibitor (TKI) Naïve Patients with Advanced NSCLC
2017
Journal of Thoracic Oncology
Aaron Lisberg
Jamie Hunt
N. Reese
T. Wang
P. Coluzzi
Marshall L. Spiegel
K. Bornazyan
J. Carroll
John Madrigal
Blanca A Ledezma
Melody A. Mendenhall
J Bui
H.Lu
A Cummings
Z. Noor
Jonathan W. Goldman
Edward B. Garon
Show All
Source
Cite
Save
Citations (0)
Diabetes and Blood Pressure Control
2010
Aaron Lisberg
Show All
Source
Cite
Save
Citations (0)
1